The first patient has been dosed in a Phase 1/2 clinical study of VTx-002, an experimental therapy for amyotrophic lateral sclerosis.
MyChesCo on MSN
Experimental Pompe therapy shows early promise in trial
PHILADELPHIA, PA — Aro Biotherapeutics reported interim data from a Phase 1b study of ABX1100, an investigational therapy for late-onset Pompe disease, showing the drug was generally well tolerated ...
In cellular and animal models of neuroblastoma, small cell lung cancer and colon cancer, this strategy reduces tumours, ...
A new study has confirmed that male and female lungs are "wired differently" at the molecular level, providing further evidence supporting sex-inclusive respiratory disease research and treatment. The ...
An experimental pill called enlicitide slashed levels of low-density lipoprotein (LDL) cholesterol, commonly known as "bad" ...
Severe accidents in nuclear reactors, though low-probability events, pose significant risks to human safety, the environment, and public trust in nuclear ...
In Phase II data released this week, people taking a monthly dose of PF’3944 continued to lose more weight than those on a ...
An experimental pain medicine met the primary goal of a late-stage clinical trial, the drug’s maker said Tuesday, setting the stage for it to seek approval from the US Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results